SPDR® S&P Biotech ETF (XBI)

Add to Watchlists
Create an Alert
80.31 +1.11  +1.40% NYSE Arca Jun 23, 20:00 Delayed 2m USD
View Full Chart
XBI Price Chart

XBI Key Stats

XBI Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 15.48% 7.50% 1
3M 18.01% 10.30% 1
6M 30.76% 19.13% 3
1Y 47.69% 19.30% 3
3Y 17.11% 10.02% 3
5Y 23.10% 18.23% 1
As of June 23, 2017
Returns for periods of 1 year and above are annualized.

XBI Asset Allocation

Type % Net % Long % Short
Cash 0.22% 0.22% 0.00
Stock 99.78% 99.78% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00 0.00 0.00
As of June 23, 2017

XBI Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00
Greater Europe 0.00
United Kingdom 0.00
Europe Developed 0.00
Europe Emerging 0.00
Africa/Middle East 0.00
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of June 23, 2017
Region breakdown data is calculated by using the long position holdings of the portfolio.

XBI Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 100.0%
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of June 23, 2017

XBI Stock Market Capitalization

Giant 5.99%
Large 12.39%
Medium 17.79%
Small 37.51%
Micro 26.32%
As of June 23, 2017

XBI Stock Style Exposure

Large Cap Value 2.07%
Large Cap Blend 6.32%
Large Cap Growth 11.13%
Mid Cap Value 0.00
Mid Cap Blend 2.16%
Mid Cap Growth 16.74%
Small Cap Value 1.29%
Small Cap Blend 9.50%
Small Cap Growth 50.79%
As of June 23, 2017
View More Holdings

XBI Top 10 Holdings

Symbol Name % Weight Price % Chg
CLVS Clovis Oncology Inc 2.91% 95.00 -1.84%
EXEL Exelixis Inc 2.28% 23.78 -1.20%
ALXN Alexion Pharmaceuticals Inc 2.21% 126.07 -0.13%
ALNY Alnylam Pharmaceuticals Inc 2.16% 85.21 +1.49%
KITE Kite Pharma Inc 2.12% 100.66 +7.10%
INCY Incyte Corp 2.12% 136.28 +0.48%
CELG Celgene Corp 2.10% 134.31 +0.47%
SRPT Sarepta Therapeutics Inc 2.06% 35.02 -1.30%
IONS Ionis Pharmaceuticals Inc 2.04% 54.97 +0.46%
BIVV Bioverativ Inc 2.03% 62.57 +2.62%
As of June 23, 2017
Advertisement

XBI Ratings

Fiduciary Score Upgrade

XBI One Page Reports

XBI Basic Info

Style
Equity Style Small Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD
100.0%

XBI Manager Info

Name Tenure
Karl Schneider 2.50 yrs
Michael Feehily 5.50 yrs
Raymond Donofrio 0.32 yrs

XBI Net Fund Flows

1M -106.14M
3M 19.04M
6M -380.66M
YTD 122.37M
1Y 575.27M
3Y 1.427B
5Y 1.509B
10Y 1.858B
As of May 31, 2017

XBI Risk Info

Beta (5Y) 1.638
Max Drawdown (All) 49.39%
Historical Sharpe (10Y) 0.6771
Historical Sortino (All) 0.9246
30-Day Rolling Volatility 25.12%
Daily Value at Risk (VaR) 1% (All) 4.89%
Monthly Value at Risk (VaR) 1% (All) 21.38%

XBI Fundamentals

Dividend Yield TTM (6-23-17) 0.22%
SEC Yield (6-23-17) -0.01%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 8.466
Weighted Average Price to Book Ratio 5.177
Weighted Median ROE -15.34%
Weighted Median ROA -21.84%
Forecasted Dividend Yield 0.24%
Forecasted PE Ratio 20.78
Forecasted Price to Sales Ratio 5.100
Forecasted Price to Book Ratio 4.068
Number of Holdings 98
As of June 23, 2017

XBI Growth Estimates

Forecasted 5 Yr Earnings Growth 11.57%
Forecasted Book Value Growth 11.96%
Forecasted Cash Flow Growth 24.02%
Forecasted Earnings Growth 17.63%
Forecasted Revenue Growth 25.03%
As of June 23, 2017

XBI Comparables

Edit

XBI Attributes

Key Dates
Inception Date 1/31/2006
Last Annual Report Date 6/30/2016
Last Prospectus Date 10/31/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XBI Excel Add-In Codes

  • Name: =YCI("XBI","name")
  • Broad Asset Class: =YCI("XBI", "broad_asset_class")
  • Broad Category: =YCI("XBI", "broad_category_group")
  • Prospectus Objective: =YCI("XBI", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.